Raffaela Campana1, Sheron Dzoro, Irene Mittermann, Elena Fedenko, Olga Elisyutina, Musa Khaitov, Alexander Karaulov, Rudolf Valenta. 1. aDivision of Immunopathology, Department of Pathophysiology and Allergy Research, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria bNRC Institute of Immunology FMBA cDepartment of Clinical Immunology and Allergy, Sechenov First Moscow State Medical University, Moscow, Russia.
Abstract
PURPOSE OF REVIEW: Molecular allergology uses pure, mainly recombinant and structurally defined allergen molecules and allergen-derived epitopes to study mechanisms of IgE-associated allergy, to diagnose, and even predict the development of allergic manifestations and to treat and prevent IgE-associated allergies. Atopic dermatitis, a chronic inflammatory skin disease is almost always associated with IgE sensitization to allergens. However, also non-IgE-mediated pathomechanisms seem to be operative in atopic dermatitis and it is often difficult to identify the disease-causing allergens. Here we review recent work showing the usefulness of molecular allergology to study mechanisms of atopic dermatitis, for diagnosis and eventually for treatment and prevention of atopic dermatitis. RECENT FINDINGS: IgE sensitization to airborne, food-derived, microbial allergens, and autoallergens has been found to be associated with atopic dermatitis. Using defined allergen molecules and non-IgE-reactive allergen derivatives, evidence could be provided for the existence of IgE- and non-IgE-mediated mechanisms of inflammation in atopic dermatitis. Furthermore, effects of epicutaneous allergen administration on systemic allergen-specific immune responses have been studied. Multi-allergen tests containing micro-arrayed allergen molecules have been shown to be useful for the identification of culprit allergens in atopic dermatitis and may improve the management of atopic dermatitis by allergen-specific immunotherapy, allergen avoidance, and IgE-targeting therapies in a personalized medicine approach. SUMMARY: Molecular allergology allows for dissection of the pathomechanisms of atopic dermatitis, provides new forms of allergy diagnosis for identification of disease-causing allergens, and opens the door to new forms of management by allergen-specific and T cells-targeting or IgE-targeting interventions in a personalized medicine approach.
PURPOSE OF REVIEW: Molecular allergology uses pure, mainly recombinant and structurally defined allergen molecules and allergen-derived epitopes to study mechanisms of IgE-associated allergy, to diagnose, and even predict the development of allergic manifestations and to treat and prevent IgE-associated allergies. Atopic dermatitis, a chronic inflammatory skin disease is almost always associated with IgE sensitization to allergens. However, also non-IgE-mediated pathomechanisms seem to be operative in atopic dermatitis and it is often difficult to identify the disease-causing allergens. Here we review recent work showing the usefulness of molecular allergology to study mechanisms of atopic dermatitis, for diagnosis and eventually for treatment and prevention of atopic dermatitis. RECENT FINDINGS: IgE sensitization to airborne, food-derived, microbial allergens, and autoallergens has been found to be associated with atopic dermatitis. Using defined allergen molecules and non-IgE-reactive allergen derivatives, evidence could be provided for the existence of IgE- and non-IgE-mediated mechanisms of inflammation in atopic dermatitis. Furthermore, effects of epicutaneous allergen administration on systemic allergen-specific immune responses have been studied. Multi-allergen tests containing micro-arrayed allergen molecules have been shown to be useful for the identification of culprit allergens in atopic dermatitis and may improve the management of atopic dermatitis by allergen-specific immunotherapy, allergen avoidance, and IgE-targeting therapies in a personalized medicine approach. SUMMARY: Molecular allergology allows for dissection of the pathomechanisms of atopic dermatitis, provides new forms of allergy diagnosis for identification of disease-causing allergens, and opens the door to new forms of management by allergen-specific and T cells-targeting or IgE-targeting interventions in a personalized medicine approach.
Authors: Georg Daeschlein; Sebastian Scholz; Stine Lutze; Ruediger Eming; Andreas Arnold; Hermann Haase; Michael Hertl; Michael Jünger Journal: Ther Apher Dial Date: 2014-12-16 Impact factor: 1.762
Authors: Marit Westman; Christian Lupinek; Jean Bousquet; Niklas Andersson; Sandra Pahr; Alexandra Baar; Anna Bergström; Mats Holmström; Pär Stjärne; Karin C Lødrup Carlsen; Kaj-Håkon Carlsen; Josep M Antó; Rudolf Valenta; Marianne van Hage; Magnus Wickman Journal: J Allergy Clin Immunol Date: 2014-12-18 Impact factor: 10.793
Authors: Yvonne Resch; Katharina Blatt; Ursula Malkus; Christian Fercher; Ines Swoboda; Margit Focke-Tejkl; Kuan-Wei Chen; Susanne Seiberler; Irene Mittermann; Christian Lupinek; Azahara Rodriguez-Dominguez; Petra Zieglmayer; René Zieglmayer; Walter Keller; Vladislav Krzyzanek; Peter Valent; Rudolf Valenta; Susanne Vrtala Journal: PLoS One Date: 2016-08-22 Impact factor: 3.240
Authors: C R Cabauatan; R Campana; K Niespodziana; C Reinisch; U Lundberg; A Meinke; R Henning; A Neubauer; R Valenta Journal: Allergy Date: 2016-09-30 Impact factor: 13.146
Authors: Yujiao Meng; Zhengrong Liu; Chunyan Zhai; Tingting Di; Lu Zhang; Lei Zhang; Xinran Xie; Yan Lin; Ning Wang; Jingxia Zhao; Yan Wang; Ping Li Journal: Mol Med Rep Date: 2019-02-25 Impact factor: 2.952
Authors: Andreas Wollenberg; Simon Francis Thomsen; Jean-Philippe Lacour; Xavier Jaumont; Slawomir Lazarewicz Journal: World Allergy Organ J Date: 2021-03-19 Impact factor: 4.084
Authors: P Schmid-Grendelmeier; R Takaoka; K C Ahogo; W A Belachew; S J Brown; J C Correia; M Correia; B Degboe; V Dorizy-Vuong; O Faye; L C Fuller; K Grando; C Hsu; K Kayitenkore; N Lunjani; F Ly; G Mahamadou; R C F Manuel; M Kebe Dia; E J Masenga; C Muteba Baseke; A N Ouedraogo; F Rapelanoro Rabenja; J Su; J N Teclessou; G Todd; A Taïeb Journal: J Eur Acad Dermatol Venereol Date: 2019-11 Impact factor: 6.166